Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

CGF therapy may effectively treat psoriasis by reducing inflammation.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Blocking a specific immune cell signal can trigger hair growth.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

γδ T cells adapt uniquely to different tissues in mice.

New cytokine-targeted therapies show promise for treating alopecia areata.

K6hf is a unique protein found only in a specific layer of hair follicles.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

The STIM1 R304W mutation in mice leads to bone changes and teeth hair growth.

Certain proteins are found at higher levels in balding areas compared to non-balding areas, suggesting a link to hair loss. This could be useful for diagnosing and treating hair loss.

The method increases stem-like cells for better skin regeneration.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

Young donor, early passage stem cells have the highest stemness.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

B6.Cg-Tyr c−2J Hr hr /J mice have a stronger delayed sunburn reaction and are good for UV research.

Suplatast tosilate successfully treated a woman's systemic sclerosis symptoms.

S100A4 and S100A6 proteins may activate stem cells for hair follicle regeneration and could be potential targets for hair loss treatments.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.